Torthaí cuardaigh - Anuradha Chakravarthy
- 1 - 3 toradh as 3 á dtaispeáint
-
1
Phase I trial of vorinostat added to chemoradiation with capecitabine in pancreatic cancer de réir Emily Chan, Lori R. Arlinghaus, Dana B. Cardin, Laura W. Goff, Jordan Berlin, Alexander A. Parikh, Richard G. Abramson, Thomas E. Yankeelov, Scott W. Hiebert, Nipun B. Merchant, Srividya Bhaskara, Anuradha Chakravarthy
Foilsithe / Cruthaithe 2016Artigo -
2
Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results de réir Thomas E. Yankeelov, Martin Lepage, Anuradha Chakravarthy, Elizabeth E. Broome, Kenneth J. Niermann, Mark C. Kelley, Ingrid M. Meszoely, Ingrid A. Mayer, Cheryl R. Herman, Kevin McManus, Ronald R. Price, John C. Gore
Foilsithe / Cruthaithe 2006Artigo -
3
Multiparametric Magnetic Resonance Imaging for Predicting Pathological Response After the First Cycle of Neoadjuvant Chemotherapy in Breast Cancer de réir Xia Li, Richard G. Abramson, Lori R. Arlinghaus, Hakmook Kang, Anuradha Chakravarthy, Vandana G. Abramson, Jaime Farley, Ingrid A. Mayer, Mark C. Kelley, Ingrid M. Meszoely, Julie Means‐Powell, Ana M. Grau, Melinda E. Sanders, Thomas E. Yankeelov
Foilsithe / Cruthaithe 2014Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Cancer
Internal medicine
Medicine
Breast cancer
Chemotherapy
Magnetic resonance imaging
Nuclear medicine
Oncology
Radiology
Adverse effect
Biochemistry
Capecitabine
Chemistry
Colorectal cancer
Complete response
Diffusion MRI
Dynamic contrast
Dynamic contrast-enhanced MRI
Effective diffusion coefficient
Gastroenterology
Gene
Histone
Histone deacetylase
Nausea
Neoadjuvant therapy
Nuclear magnetic resonance
Pancreatic cancer
Pathological
Phases of clinical research
Physics